E-Books →Innovation, Commercialization, and Start-Ups in Life Sciences, 2nd Edition

Written by an expert who has worked with more nearly 500 life science start-ups, this book discusses specific processes and investor milestones that must be navigated to align customer, funder, and acquirer needs. Successful commercialization requires attention to multiple constituents, such as investors, regulators, and customers. Investors require liquidity for their return, which is achieved through selling their stock in a public or private sale. The reader will gain an appreciation for the necessary data, partnerships, and skills needed to create a competitive and sustainable company. The author discusses such specific issues as customer problems, demonstrating sales access, and ensuring intellectual property is impervious to competitive advancement. This book is intended to be suitable for entrepreneurs, venture capitalists, and investors in both business and academic settings. These organizations have specific departments, such as R&D, operations, business development, legal, regulatory, and marketing, that would also benefit from this book.

FEATURES

• Focuses specifically on life science start-ups
  
• Examines how to determine a company valuation and future "fundable milestones"
  
• Explores how to align regulatory and clinical strategies
  
• Discusses intellectual property derived from a university or individual through formation to exit.
  
• Reviews how start‐ups must simultaneously meet the needs of multiple constituencies at once: investors, regulators, customers and exit candidates
  

James F. Jordan is an author, consultant, and speaker. He is a Distinguished Service Professor of Healthcare & Biotechnology Management, a former Fortune 100 executive, and a managing director of a venture fund.
Access the Support Material:https://healthcaredata.center/
Cover design by Sarah Mailhott.